Literature DB >> 25900211

Prognostic value of continued smoking on survival and recurrence rates in patients with head and neck cancer: A systematic review.

Lieke C R van Imhoff1, Gabriëlle G J Kranenburg1, Sven Macco1, Nicoline L Nijman1, Elisabeth J van Overbeeke1, Inge Wegner1,2, Wilko Grolman1,2, Ajit J Pothen1.   

Abstract

BACKGROUND: The purpose of this systematic review was to determine the prognostic value of continued smoking after diagnosis on survival and recurrence rates in head and neck cancer.
METHODS: A systematic search was performed and predefined inclusion and exclusion criteria were used to screen and select the articles. The remaining articles were critically appraised.
RESULTS: Six articles were used for data extraction. The survival rate of patients who continued to smoke was 21% to 35% lower compared with patients who quit smoking. The recurrence rate for continued smoking was 23% and 30% higher. In 1 study, there was no difference between continuation and cessation of smoking, and 1 study showed a higher recurrence rate for patients who continued to smoke, which was not statistically significant.
CONCLUSION: There is consistent evidence that survival rates are lower and recurrence rates are higher for patients who continue to smoke after being diagnosed with head and neck cancer.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E2214-E2220, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  head and neck cancer; head and neck squamous cell carcinoma (HNSCC); recurrence; smoking; survival

Mesh:

Year:  2015        PMID: 25900211     DOI: 10.1002/hed.24082

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  25 in total

1.  Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma.

Authors:  Samir S Khariwala; Dorothy K Hatsukami; Irina Stepanov; Nathan Rubin; Heather H Nelson
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-06-01       Impact factor: 6.223

2.  The course of swallowing problems in the first 2 years after diagnosis of head and neck cancer.

Authors:  Jorine A Vermaire; Cornelis P J Raaijmakers; Evelyn M Monninkhof; C René Leemans; Robert J Baatenburg de Jong; Robert P Takes; Irma M Verdonck-de Leeuw; Femke Jansen; Johannes A Langendijk; Chris H J Terhaard; Caroline M Speksnijder
Journal:  Support Care Cancer       Date:  2022-08-30       Impact factor: 3.359

3.  Persistent Tobacco Use After Treatment for Head and Neck Cancer.

Authors:  Tyler Van Heest; Nathan Rubin; Samir S Khariwala
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2022-07-01       Impact factor: 8.961

Review 4.  Psychosocial Issues in Patients with Head and Neck Cancer: an Updated Review with a Focus on Clinical Interventions.

Authors:  Joshua D Smith; Andrew G Shuman; Michelle B Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

5.  DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes.

Authors:  Devin C Koestler; Joseph Usset; Brock C Christensen; Carmen J Marsit; Margaret R Karagas; Karl T Kelsey; John K Wiencke
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-13       Impact factor: 4.254

6.  Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era.

Authors:  Lauren J Beesley; Peter G Hawkins; Lahin M Amlani; Emily L Bellile; Keith A Casper; Steven B Chinn; Avraham Eisbruch; Michelle L Mierzwa; Matthew E Spector; Gregory T Wolf; Andrew G Shuman; Jeremy M G Taylor
Journal:  Cancer       Date:  2018-10-06       Impact factor: 6.860

7.  Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients.

Authors:  Juliane Friemel; Ronja Foraita; Kathrin Günther; Mathias Heibeck; Frauke Günther; Maren Pflueger; Hermann Pohlabeln; Thomas Behrens; Jörn Bullerdiek; Rolf Nimzyk; Wolfgang Ahrens
Journal:  BMC Oral Health       Date:  2016-03-11       Impact factor: 2.757

8.  The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies.

Authors:  Zhisen Shen; Chongchang Zhou; Jinyun Li; Hongxia Deng; Qun Li; Jian Wang
Journal:  Onco Targets Ther       Date:  2016-10-31       Impact factor: 4.147

9.  Impact of age and comorbidity on survival among patients with oral cavity squamous cell carcinoma.

Authors:  Krupal B Patel; Daniel Martin; Songzhu Zhao; Bhavna Kumar; Ricardo Carrau; Enver Ozer; Amit Agrawal; Stephen Kang; James W Rocco; David Schuller; Theodoros Teknos; Guy Brock; Matthew Old
Journal:  Head Neck       Date:  2020-09-30       Impact factor: 3.147

10.  Informational and Support Needs of Patients with Head and Neck Cancer: Current Status and Emerging Issues.

Authors:  Carolyn Y Fang; Carolyn J Heckman
Journal:  Cancers Head Neck       Date:  2016-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.